3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
3
Unknown
2
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
6
Genitourinary
5
Gastrointestinal
3
Gynecologic
2
Thoracic
1
Sarcoma
1
CNS
1
Conditions
Uterine Cervical Neoplasms
2
Endometrial Neoplasms
1
Interventions
pembrolizumab
45
Paclitaxel
45
Carboplatin
39
Magnetic Resonance Spectroscopy
28
olaparib
27
Specimen Handling
26
Cisplatin
24
Bevacizumab
20
Nivolumab
18
Taxes
17
Biopsy
16
Gemcitabine
13
Cyclophosphamide
13
durvalumab
12
Immunoglobulin G
11
Doxorubicin
11
Disulfides
11
Surveys and Questionnaires
10
niraparib
9
liposomal doxorubicin
9
dostarlimab
9
Radiotherapy
8
Brachytherapy
8
lenvatinib
7
fludarabine
7
atezolizumab
7
Letrozole
7
Docetaxel
7
cediranib
6
Platinum
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Radiation Dose Hypofractionation
×
Gynecologic
×
Clear all
NCT07605507
2026-05-26
HYPOCx-iRex
Siriraj Hospital
Phase NA
Active not recruiting
40 enrolled
NCT05139368
2024-11-18
RT-PACE
University of Utah
Phase NA
Active not recruiting
22 enrolled